POM-V Prescription Required Companion Animal

Anivac VHD Suspension for Injection for Rabbits

Active ingredient: Rabbit hemorrhagic disease virus

Form

Injection

Species

Rabbits

Manufacturer

Pharmagal Bio s. r .o.

VMD MA No.

33225/4000

What it's used for

For active immunisation of rabbits to prevent mortality caused by RHD virus Onset of immunity: 7 days Duration of immunity: 1 year based on field data with...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Rabbit hemorrhagic disease v...

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Anivac VHD Suspension for Injection for Rabbits — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

For active immunisation of rabbits to prevent mortality caused by RHD virus
Onset of immunity: 7 days
Duration of immunity: 1 year based on field data without controlled challenge

The vaccine dose for all age categories is 0.5 ml.
1 dose of 0.5 ml per rabbit, administered subcutaneously, it is recommended to localise
the site of administration to the lateral thoracic wall.
Primary vaccination: 1 injection in rabbits from the age of 10 weeks.
Booster: 1 injection every 12 months
With respect to the epizootological situation, it is possible to vaccinate rabbits younger
than 10 weeks (but not earlier than at the age of six weeks) with subsequent revaccination
4 weeks after the first vaccination.
Shake well before and occasionally during administration.

None.

No information is available on the use of the vaccine in seropositive animals including
those with maternally derived antibodies; therefore in situations where high antibody levels
are expected the vaccination protocol should be planned accordingly.

Special precautions for use in animals
Do not vaccinate unhealthy animals.
It is recommended not to vaccinate in the later stages of pregnancy in order to avoid stress
and handling of pregnant does.
Special precautions to be taken by the person administering the medicinal product
to animals
In case of accidental self-injection, seek medical advice immediately and show the
package leaflet or the label to the physician.

No information is available on the safety and efficacy of this vaccine when used with any
other veterinary medicinal product. A decision to use this vaccine before or after any other
veterinary medicinal product therefore needs to be made on a case by case basis.

Store in a refrigerator (2 °C – 8 °C). Protect from frost.
Once opened, store below 25°C.

Special precautions for use in animals
Do not vaccinate unhealthy animals.
It is recommended not to vaccinate in the later stages of pregnancy in order to avoid stress
and handling of pregnant does.
Special precautions to be taken by the person administering the medicinal product
to animals
In case of accidental self-injection, seek medical advice immediately and show the
package leaflet or the label to the physician.
4.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.